Inovalon Investors' Revived Chancery Suit Moves Forward
A Delaware chancellor sent into discovery investors' claim that Inovalon didn't properly disclose that a consortium of private equity firms that bought the healthcare data company paid $400 million in fees...To view the full article, register now.
Already a subscriber? Click here to view full article